YOLFTbeta
Acarix A/S

Acarix A/S

ACARIX · ST · Healthcare / Medical Devices

0.1752SEK+0.00 (+2.82%)

Price History

Full chart

Market Stats

Previous Close0.1704
Open0.1704
Day Range0.167 – 0.1754
52-Week Range0.18 – 0.349
Volume859.04K
Market Cap259.89M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta-0.21
50-Day Avg0.23
200-Day Avg0.2588

About

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Aamir Mahmood
  • Employees8
  • HeadquartersRegus MalmOe, Malmö, Sweden, 215 32, Sweden
  • Websitehttps://www.acarix.com

Leadership

  • Mr. Aamir MahmoodPresident & CEO · b. 1976
  • Mr. Christian LindholmCFO & Executive VP · b. 1964
  • Ms. Carma ConnelyHead of Operations & Customer Excellence · b. 1975
  • Mr. Andrew TurkDirector of Sales · b. 1978
  • Dr. George Chrysant M.D.Chief Medical Advisor · b. 1970
  • Mr. Jeffrey RuddHead of US Finance · b. 1977
  • Mr. Beji GeorgeHead of Global Strategy & Therapy Development · b. 1978

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue000638.00K1.02M1.86M2.17M3.76M5.82M6.24M6.20M7.36M
Growth (%)----+60.50%+81.35%+16.86%+73.27%+54.84%+7.20%-0.62%+18.69%
Cost of Revenue18.90M8.67M0208.00K316.00K427.00K576.00K937.00K1.20M944.00K607.00K4.60M
Gross Profit-18.90M-8.67M0430.00K708.00K1.43M1.59M2.82M4.62M5.30M5.59M2.76M
Gross Margin---67.40%69.14%77.01%73.46%75.08%79.37%84.87%90.21%37.51%
Operating Expense5.09M6.70M26.79M31.17M43.23M47.87M43.02M54.52M81.10M82.85M71.97M50.77M
Operating Income-23.99M-15.38M-26.79M-30.74M-42.52M-46.44M-41.43M-51.70M-76.47M-77.55M-66.37M-48.01M
Operating Margin----4818.65%-4152.64%-2500.97%-1909.26%-1374.89%-1313.55%-1242.64%-1070.19%-652.25%
EBITDA-23.83M-15.25M-51.05M-29.30M-41.99M-44.58M-40.29M-50.52M-76.12M-77.12M-62.63M-44.53M
EBITDA Margin----4592.95%-4100.68%-2400.65%-1856.64%-1343.59%-1307.40%-1235.73%-1009.84%-605.01%
Net Income-19.21M-12.39M-48.24M-29.78M-42.27M-46.46M-41.55M-51.80M-76.98M-77.84M-66.19M-48.09M
Net Income Margin----4667.08%-4128.03%-2501.83%-1914.65%-1377.71%-1322.31%-1247.22%-1067.19%-653.32%
R&D18.90M8.67M1.25M5.29M12.34M20.28M14.47M21.49M27.76M28.52M25.39M14.76M
R&D as % of Total Revenue---829.00%1205.47%1092.19%666.77%571.62%476.78%456.91%409.30%200.45%
Interest Expense04.00K1.45M95.00K21.00K56.00K52.00K71.00K163.00K132.00K267.00K485.00K
Interest Expense % of Total Revenue---14.89%2.05%3.02%2.40%1.89%2.80%2.12%4.31%6.59%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets18.28M15.58M173.29M134.06M95.20M82.98M89.95M118.60M69.48M62.88M80.76M48.33M
Total Liabilities3.16M3.44M17.77M5.12M7.32M6.38M7.81M18.06M17.66M11.00M5.06M10.16M
Total Equity15.12M12.14M155.52M128.94M87.88M76.60M82.14M100.54M51.83M51.88M75.70M38.17M
Cash8.71M2.12M145.90M103.41M64.97M53.70M64.06M15.81M11.16M35.15M53.99M18.27M
Total Debt-----766.00K1.37M523.00K251.00K---
Net Debt-8.71M-2.12M-145.90M-103.41M-64.97M-52.93M-62.70M-15.29M-10.91M-35.15M-53.99M-18.27M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-20.87M-8.63M-9.06M-40.54M-38.61M-44.53M-36.69M-48.01M-74.87M-81.37M-63.33M-48.38M
Investing Cash Flow-810.00K-6.52M-12.20M-2.98M-43.00K-10.00K-43.00K-43.00K-151.00K0-920.00K-757.00K
Financing Cash Flow14.50M8.84M165.65M1.20M33.03M33.03M47.35M-164.00K69.03M106.23M86.98M11.11M
Capital Expenditure810.00K6.52M12.20M2.98M43.00K43.00K43.00K43.00K151.00K22.00K920.00K757.00K
Free Cash Flow-21.68M-15.15M-21.26M-43.52M-38.61M-44.53M-36.69M-48.05M-75.02M-81.37M-64.25M-49.14M
FCF to OCF103.88%175.54%234.73%107.36%100.00%100.00%100.00%100.09%100.20%100.00%101.45%101.56%

Earnings

Report DateFeb 23, 2017May 24, 2017Feb 26, 2018May 23, 2018Aug 21, 2018Nov 14, 2018Feb 20, 2019May 17, 2019Aug 6, 2019Nov 14, 2019Feb 20, 2020May 14, 2020Aug 7, 2020Nov 12, 2020Feb 18, 2021May 11, 2021Aug 19, 2021Nov 11, 2021Feb 17, 2022May 11, 2022Aug 25, 2022Nov 16, 2022Feb 15, 2023May 11, 2023Aug 31, 2023Nov 9, 2023Feb 15, 2024May 14, 2024Aug 22, 2024Nov 7, 2024Feb 13, 2025May 14, 2025Aug 21, 2025Nov 7, 2025Feb 13, 2026May 19, 2026Aug 14, 2026
EPS Estimate-------------------------------------
EPS Actual-0.33-0.08-0.28-0.17-0.21-0.28-0.26-0.28-0.27-0.25-0.23-0.21-0.18-0.11-0.08-0.08-0.09-0.08-0.09-0.06-0.07-0.08-0.09-0.04-0.05-0.04-0.03-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.01
Surprise-------------------------------------
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap259.89M
Enterprise Value220.57M
Trailing P/E0.00
Forward P/E0.00
Price / Sales28.18
Price / Book5.74
EPS-0.04
Book Value0.035
Revenue (TTM)9.22M
Gross Profit (TTM)7.67M
EBITDA-37.94M
Profit Margin0.00%
Operating Margin-403.73%
Return on Equity-86.08%
Return on Assets-48.33%
Shares Outstanding1.24B
Shares Float1.10B
Beta-0.21
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 29, 202372:65
  • Dec 12, 2022203:186
  • Nov 29, 2021637:589
  • Aug 17, 20201481:1300
  • Oct 3, 2019545:368